GenVivo to Present Phase 1 Trial Results for GEN2, A Personalizing Systemic Cancer Immunotherapy, at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GEN2 was evaluated in adult patients with advanced solid tumors in an intravenous dose escalation Phase 1 study GEN2 is well-tolerated, with no Dose Limiting Toxicity or treatment-related ...

A Car from the 1950s Ignited Devin Booker’s Love of Collecting

Devin Booker's car collection is expansive, and an unexpected ride from the 1950s started it all for the NBA star.
Jonny Builds on MSN

DIY Coffee Table w/ Hidden Wireless Charging | Converts to Ottoman | CNC

This week, I’ll show you how I made a DIY coffee table with hidden wireless charging. The coffee table converts into an ...
Le Lézard

Vector BioMed Expands LENTIVERSEtm Platform and Unveils New Brand Identity to Close the Gap Between CGT Innovation and Patient Access

Vector BioMed, a leading lentiviral vector supplier and contract vector development and manufacturing organization (CVDMO), today announced the expansion of its LENTIVERSEtm platform alongside the ...